ConductScience.org, home

Gene · 2823

GPM6A: glycoprotein M6A

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. GPM6A: glycoprotein M6A. Genes, record 2823. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/2823

On this page

Gene

Symbol
GPM6A
HGNC
Name
glycoprotein M6A
HGNC
NCBI Gene ID
2823
NCBI Gene
HGNC ID
HGNC:4460
HGNC
Ensembl
ENSG00000150625
NCBI Gene
Aliases
GPM6, M6A
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P51674Neuronal membrane glycoprotein M6-a2780Ensembl, GeneID, HGNC

Source UniProt

Patents43

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4641201 A22025-10-292632P51674Espacenet
JP 2025529142 A2025-09-041772P51674Espacenet
US 12371689 B22025-07-291772P51674Espacenet
JP 2025517969 A2025-06-122632P51674Espacenet
JP 2024178415 A2024-12-24403P51674Espacenet
JP 2024123008 A2024-09-106359P51674Espacenet
JP 2024123008 A2024-09-106360P51674Espacenet
US 11446398 B22022-09-2035666P51674Espacenet
US 11446398 B22022-09-2035667P51674Espacenet
US 11400116 B22022-08-023246P51674Espacenet

1 to 10 of 43

See all 43 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants872

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleGPM6A papersNewest fiscal year
RM1HG008935Center for dynamic RNA epitranscriptomes - Renewal112025
P30CA008748Cancer Center Support Grant42025
P30CA016672Cancer Center Support Grant42025
P30CA014599Cancer Center Support Grant32025
P30CA033572Cancer Center Support Grant32025
P30CA054174Mays Cancer Center at UT Health SA32025
R01CA124332Regulation of KSHV replication by N6-methyladenosine (m6A)32025
R01CA186702Mechanisms of epitranscriptomic regulation in cancer32025
R35NS111631New mechanisms and technologies for understanding post-transcriptional gene regulation in neurons32025
I01BX001882Post-Translational Control of TET Function in Lymphoma22025

1 to 10 of 872Source NIH's project files

See all 872 nih grants

Papers1,924

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Development of m6A Readers for Enhanced Recognition In Vitro via Genetic Code Expansion.ACS Chem Biol202642715419PubTator, text miningPubMed
M6A-regulated LncRNA7825 maintains epithelial barrier integrity to restrict bacterial infection.Int Immunopharmacol202642485757PubTator, text miningPubMed
The lncRNA-m6A axis in cancer: a bidirectional regulatory network in tumor progression and therapeutic resistance.J Transl Med202642400056PubTator, text miningPubMed
Pseudorabies virus hijacks JNK to reprogram m6A machinery for sustaining replication.Microbiol Res202642398312PubTator, text miningPubMed
Optimizing NGN2 Dosage Enhances the Neuronal Enrichment of iPSC-Derived Neuronal Cultures.Mol Cell Proteomics202642309337PubTator, text miningPubMed
The YTHDC1-m6A-GADD45B axis promotes chondrogenesis of hPDLSCs via suppressing senescence through p53/p21 signalling pathway.Int J Oral Sci202642297785PubTator, text miningPubMed
m6A-modified ATF4 regulates glucose/lipid metabolism via the Sestrin2/GSK3β axis to alleviate myocardial ischemia-reperfusion injury.J Cardiothorac Surg202642286721PubTator, text miningPubMed
Regulation of trophoblast fusion dysfunction in preeclampsia by the NCK1/EIF3D/PPARG axis.Biol Res202642271516PubTator, text miningPubMed
FTO promotes cancer progression by regulating VGLL4 m6A levels to activate STAT3 signaling in triple-negative breast cancer.J Biol Chem202642264087PubTator, text miningPubMed
FTO-mediated m6A demethylation of BCL6 promotes gastric cancer progression by suppressing ferroptosis.RNA Biol202642262009PubTator, text miningPubMed

1 to 10 of 1,924

See all 1,924 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/2823

GET https://conductscience.org/api/genes/v1/2823/patents?page=2